The first steps in gene therapy for achromatopsia
May 14, 2021
Mark Pennesi, M.D., Ph.D., says, preliminary results of two Phase 1/2 clinical trials evaluating experimental gene therapy treatments for achromatopsia, which impairs color vision, indicate the treatments can produce “encouraging signs of biologic activity.”